At this time of the year, individuals suffering from asthma find asthmatic symptoms can be significantly exacerbated by allergens associated with changing weather. For these individuals, standard asthma medications and treatments often do not remedy these unique seasonal allergy symptoms, especially those associated with Spring season. For this reason, during the period approaching Spring, many asthma sufferers begin to seek out additional asthma treatment options to remedy complications created by allergens.
Xolair, manufactured and distributed by Genetech, Inc., and Novartis Pharmaceutical Corporation, is a leading FDA approved prescription drug used in the treatment of asthma attributed to allergens. Xolair lends its success to the control over IgE, the natural occurring biological component, within our body, by suppressing the IgE overproduction which attributes to the allergic reaction in asthmatic patients.
With the ability to control IgE production, Xolair can be used in patients over the age of 12, treating allergen induced asthma simply with the application of injectable Xolair, in the office, on average, ever two to four weeks, just below the skin. Dosing will, of course, vary depending on the degree to which the patient suffers from asthma symptoms associated from allergen induced spikes in naturally occurring physiological IgE.
As with most FDA approved drugs, Xolair, in the treatment of allergen induced asthma, does not come without side effects. In studies, the most common Xolair side effects include mild headache, tingling or slight soreness of the throat and even symptoms associated with sinus drainage or an upper respiratory tract infection. At the Xolair injection site, some asthmatic patients, using Xolair to treat allergen asthma, may notice bruising and some slight swelling. While this is normal, these injection side effects should remedy within a week or so and, when not remedied during this period, should be examined by a healthcare professional.
For patients with year round asthma symptoms, the use of Xolair is approved for use as a supplement prescription drug during peak periods of allergy season. Most often, asthma patients who ordinarily use steroid inhalers will find the use of Xolair injections beneficial during the peak allergy season. During pregnancy, however, Xolair should be used at minimum due to the potential allergen associated antibodies which may develop within the fetus.
Each Spring, Americans across the country suffer from asthmatic symptoms associated with peak allergy season. When suffering from wheezing, difficulty breathing, sneezing and irritation of the eyes, nose and ears, consider using Xolair in the treatment of your allergic asthma.